What patents cover olodaterol, and who holds them?
Boehringer Ingelheim markets olodaterol (the active ingredient) as a long-acting bronchodilator in products such as Striverdi Respimat. Patent coverage for olodaterol is typically split across different “layers,” including molecules, specific formulations, delivery devices, and improvements in use. However, the specific patent titles, numbers, and assignees depend on the country and the patent family involved, and those details are not provided in the available information you shared.
Are Boehringer’s olodaterol patents still in force?
Whether Boehringer’s olodaterol-related patents are still in force depends on:
- the filing date (most patents run about 20 years from the earliest priority date),
- any granted patent term extensions (common in some jurisdictions for pharmaceutical products),
- and whether the relevant claims are still active in a given country.
Without a specific jurisdiction (e.g., US, EP, UK, Germany, etc.) and without patent numbers or filing dates, it’s not possible to determine current status from the provided prompt alone.
When do olodaterol exclusivity or patents expire?
Drug exclusivity and patent expiry timelines can differ from each other and from molecule patent expiry. Expiration can also vary by country due to different rules for:
- supplementary protection certificates (SPCs),
- regulatory data exclusivity,
- and patent term adjustments/deferrals.
You’ll need either (a) the target country or (b) the specific patent numbers/family to calculate or verify when olodaterol protections expire.
Why do people search “olodaterol Boehringer patents” (generics/biosimilars)
Search intent behind this phrase usually relates to whether another company can market a generic or follow-on product for olodaterol before Boehringer’s protections end. To assess that, you normally check:
- molecule patents and formulation patents,
- whether any SPCs extend exclusivity,
- and whether any later “product-specific” patents (device, dose regimen, combinations) remain active.
What should you check if you’re trying to confirm patent coverage yourself?
If you want to confirm Boehringer’s patent landscape for olodaterol, the practical next steps are to:
1. Pick the jurisdiction(s) you care about.
2. Find the olodaterol patent families in that jurisdiction (assignee/owner will show up in the record).
3. Check the current legal status (active, expired, lapsed, under appeal).
4. If applicable, check SPC and listed registrations tied to the marketing authorization.
If you share a country, I can narrow it down
If you tell me the jurisdiction you mean (for example, US vs EP/UK vs Germany) and whether you want molecule patents, formulation patents, or device-related patents, I can help you structure the exact patent search and what to look for in the results.